SESN looks like it could see $1 before it reverses. This company has a ton going for it but Management screwed the pooch. Their financing they just did was horrible. They had enough cash to get them through the FDA approval of their drug but they turn around and issue more shares and warrants to boot. I think this still has some potential but management needs to get the FK out of the way.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.